Targeted therapy: ready for prime time?
Cancer Treat Res
.
2004;120:1-15.
doi: 10.1007/1-4020-7856-0_1.
Authors
Caroline Seynaeve
1
,
Jaap Verweij
Affiliation
1
Dept. of Medical Oncology, Erasmus University Medical Centre-Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands.
PMID:
15217215
DOI:
10.1007/1-4020-7856-0_1
No abstract available
Publication types
Review
MeSH terms
Antineoplastic Agents / administration & dosage*
Drug Delivery Systems*
Humans
Soft Tissue Neoplasms / drug therapy*
Substances
Antineoplastic Agents